Envío gratis siempre a todo México.
Haz clic para hacer zoom
Not Available
Fluoropyrimidines in Cancer Therapy
Cargando comentarios…
Comparte
$2,139
$1,925
Envío gratis siempre
Comentarios
Cargando el resumen…
Cargando comentarios…
product
3366664Fluoropyrimidines in Cancer Therapyhttps://www.gandhi.com.mx/fluoropyrimidines-in-cancer-therapy-9781592593378/phttps://gandhi.vtexassets.com/arquivos/ids/2679966/558154cd-a958-4c6a-a73f-ee629616d133.jpg?v=63838430573073000019252139MXNHumana PressInStock/Ebooks/<p>Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors. The authors discuss the potential advantages and disadvantages of these varied drugs and their mode of administration. Based on historical results with these agents when used alone, they also present a rationale for their results when used in combination with other agents.</p>...3302862Fluoropyrimidines in Cancer Therapy19252139https://www.gandhi.com.mx/fluoropyrimidines-in-cancer-therapy-9781592593378/phttps://gandhi.vtexassets.com/arquivos/ids/2679966/558154cd-a958-4c6a-a73f-ee629616d133.jpg?v=638384305730730000InStockMXN99999DIEbook20029781592593378_W3siaWQiOiI0NzZhOTg5NC01Y2IyLTRmMzItYWEzMS04N2Y4ZjFmNzYzNzQiLCJsaXN0UHJpY2UiOjIxMzksImRpc2NvdW50IjoyMTQsInNlbGxpbmdQcmljZSI6MTkyNSwiaW5jbHVkZXNUYXgiOnRydWUsInByaWNlVHlwZSI6Ildob2xlc2FsZSIsImN1cnJlbmN5IjoiTVhOIiwiZnJvbSI6IjIwMjUtMDUtMjNUMTk6MDA6MDBaIiwidG8iOiIyMDI1LTA2LTMwVDIzOjU5OjU5WiIsInJlZ2lvbiI6Ik1YIiwiaXNQcmVvcmRlciI6ZmFsc2V9LHsiaWQiOiIzMjU0MmE1Yi1hOTdmLTRhNWMtOThiNS04YWU3NTRkNjk3YTQiLCJsaXN0UHJpY2UiOjIxNjgsImRpc2NvdW50IjoyMTcsInNlbGxpbmdQcmljZSI6MTk1MSwiaW5jbHVkZXNUYXgiOnRydWUsInByaWNlVHlwZSI6Ildob2xlc2FsZSIsImN1cnJlbmN5IjoiTVhOIiwiZnJvbSI6IjIwMjUtMDctMDFUMDA6MDA6MDBaIiwicmVnaW9uIjoiTVgiLCJpc1ByZW9yZGVyIjpmYWxzZX1d9781592593378_<p>Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors. The authors discuss the potential advantages and disadvantages of these varied drugs and their mode of administration. Based on historical results with these agents when used alone, they also present a rationale for their results when used in combination with other agents.</p>...9781592593378_Humana Presslibro_electonico_8222a6d9-1cd5-360a-928e-12db4bc20e4f_9781592593378;9781592593378_9781592593378InglésMéxico2002-12-02T00:00:00+00:00Humana Press